Morgan Stanley Nant Health, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.61 $13,214 - $21,213	-34,776 Reduced 80.07%	8,656 $2,000
Q2 2022 Oct 27, 2022	BUY	$0.42 - $0.78 $13,133 - $24,391	31,271 Added 257.14%	43,432 $18,000
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.78 $13,133 - $24,391	31,271 Added 257.14%	43,432 $18,000
Q1 2022 Oct 27, 2022	SELL	$0.75 - $1.08 $23,453 - $33,772	-31,271 Reduced 72.0%	12,161 $9,000
Q1 2022 May 13, 2022	BUY	$0.75 - $1.08 $5,322 - $7,664	7,097 Added 140.15%	12,161 $9,000
Q4 2021 Feb 14, 2022	SELL	$0.94 - $1.85 $67,563 - $132,970	-71,876 Reduced 93.42%	5,064 $5,000
Q3 2021 Nov 15, 2021	BUY	$1.61 - $2.41 $123,873 - $185,425	76,940 New	76,940 $123,000

Ticker NH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 115,550,000
Market Cap $48.5M
Description
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Ev...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.